A single injection of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) was observed to result in a decrease in serum IL-6, TNF-α, and TGF-β1 levels in the early stage of DKD (8 weeks after STZ injection). Here, TGFB1 is linked to diabetic kidney disease.